XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Beginning balance (in shares) at Dec. 31, 2020   91,502,461      
Beginning balance at Dec. 31, 2020 $ 130,670 $ 915 $ 1,176,647 $ (1,046,889) $ (3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Recognition of stock-based compensation 1,099   1,099    
Exercise of stock options (in shares)   31,811      
Exercise of stock options 79 $ 1 78    
Unrealized gain (loss) on marketable securities (6)       (6)
Net loss (9,927)     (9,927)  
Ending balance (in shares) at Mar. 31, 2021   91,534,272      
Ending balance at Mar. 31, 2021 121,915 $ 916 1,177,824 (1,056,816) (9)
Beginning balance (in shares) at Dec. 31, 2020   91,502,461      
Beginning balance at Dec. 31, 2020 130,670 $ 915 1,176,647 (1,046,889) (3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (31,816)        
Ending balance (in shares) at Sep. 30, 2021   91,609,165      
Ending balance at Sep. 30, 2021 102,909 $ 916 1,180,701 (1,078,705) (3)
Beginning balance (in shares) at Mar. 31, 2021   91,534,272      
Beginning balance at Mar. 31, 2021 121,915 $ 916 1,177,824 (1,056,816) (9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Recognition of stock-based compensation 1,275   1,275    
Issuance of stock under Employee Stock Purchase Plan (in shares)   20,791      
Issuance of stock under Employee Stock Purchase Plan 68   68    
Exercise of stock options (in shares)   41,306      
Exercise of stock options 48   48    
Unrealized gain (loss) on marketable securities 6       6
Net loss (10,838)     (10,838)  
Ending balance (in shares) at Jun. 30, 2021   91,596,369      
Ending balance at Jun. 30, 2021 112,474 $ 916 1,179,215 (1,067,654) (3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Recognition of stock-based compensation 1,464   1,464    
Exercise of stock options (in shares)   12,796      
Exercise of stock options 22   22    
Net loss (11,051)     (11,051)  
Ending balance (in shares) at Sep. 30, 2021   91,609,165      
Ending balance at Sep. 30, 2021 $ 102,909 $ 916 1,180,701 (1,078,705) (3)
Beginning balance (in shares) at Dec. 31, 2021 91,645,369 91,645,369      
Beginning balance at Dec. 31, 2021 $ 90,707 $ 916 1,182,225 (1,092,325) (109)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Recognition of stock-based compensation 1,718   1,718    
Unrealized gain (loss) on marketable securities (342)       (342)
Net loss (16,109)     (16,109)  
Ending balance (in shares) at Mar. 31, 2022   91,645,369      
Ending balance at Mar. 31, 2022 $ 75,974 $ 916 1,183,943 (1,108,434) (451)
Beginning balance (in shares) at Dec. 31, 2021 91,645,369 91,645,369      
Beginning balance at Dec. 31, 2021 $ 90,707 $ 916 1,182,225 (1,092,325) (109)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares) 0        
Net loss $ (45,343)        
Ending balance (in shares) at Sep. 30, 2022 96,398,360 96,398,360      
Ending balance at Sep. 30, 2022 $ 55,745 $ 964 1,192,928 (1,137,668) (479)
Beginning balance (in shares) at Mar. 31, 2022   91,645,369      
Beginning balance at Mar. 31, 2022 75,974 $ 916 1,183,943 (1,108,434) (451)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Recognition of stock-based compensation 1,966   1,966    
Issuance of stock under Employee Stock Purchase Plan (in shares)   169,296      
Issuance of stock under Employee Stock Purchase Plan 149 $ 2 147    
Unrealized gain (loss) on marketable securities (104)       (104)
Net loss (15,940)     (15,940)  
Ending balance (in shares) at Jun. 30, 2022   91,814,665      
Ending balance at Jun. 30, 2022 62,045 $ 918 1,186,056 (1,124,374) (555)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of shares in connection with 2021 Sales Agreement, net of fees of $0.7 million for issuance of shares (in shares)   4,583,695      
Issuance of shares in connection with 2021 Sales Agreement, net of fees of $0.7 million for issuance of shares 5,594 $ 46 5,548    
Recognition of stock-based compensation 1,324   1,324    
Unrealized gain (loss) on marketable securities 76       76
Net loss $ (13,294)     (13,294)  
Ending balance (in shares) at Sep. 30, 2022 96,398,360 96,398,360      
Ending balance at Sep. 30, 2022 $ 55,745 $ 964 $ 1,192,928 $ (1,137,668) $ (479)